U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Unknown
149124
Name Type Language
LULIZUMAB PEGOL
INN   USAN   WHO-DD  
INN   USAN  
Official Name English
lulizumab pegol [INN]
Preferred Name English
Lulizumab pegol [WHO-DD]
Common Name English
BMS-931699
Code English
LULIZUMAB PEGOL [USAN]
Common Name English
Code System Code Type Description
WIKIPEDIA
Lulizumab pegol
Created by admin on Mon Mar 31 22:09:23 GMT 2025 , Edited by admin on Mon Mar 31 22:09:23 GMT 2025
PRIMARY
DRUG BANK
DB15441
Created by admin on Mon Mar 31 22:09:23 GMT 2025 , Edited by admin on Mon Mar 31 22:09:23 GMT 2025
PRIMARY
EVMPD
SUB179558
Created by admin on Mon Mar 31 22:09:23 GMT 2025 , Edited by admin on Mon Mar 31 22:09:23 GMT 2025
PRIMARY
SMS_ID
100000164922
Created by admin on Mon Mar 31 22:09:23 GMT 2025 , Edited by admin on Mon Mar 31 22:09:23 GMT 2025
PRIMARY
FDA UNII
LCT264LTYE
Created by admin on Mon Mar 31 22:09:23 GMT 2025 , Edited by admin on Mon Mar 31 22:09:23 GMT 2025
PRIMARY
CAS
1421830-13-8
Created by admin on Mon Mar 31 22:09:23 GMT 2025 , Edited by admin on Mon Mar 31 22:09:23 GMT 2025
PRIMARY
INN
9940
Created by admin on Mon Mar 31 22:09:23 GMT 2025 , Edited by admin on Mon Mar 31 22:09:23 GMT 2025
PRIMARY
NCI_THESAURUS
C175727
Created by admin on Mon Mar 31 22:09:23 GMT 2025 , Edited by admin on Mon Mar 31 22:09:23 GMT 2025
PRIMARY
USAN
AB-119
Created by admin on Mon Mar 31 22:09:23 GMT 2025 , Edited by admin on Mon Mar 31 22:09:23 GMT 2025
PRIMARY
ChEMBL
CHEMBL3137354
Created by admin on Mon Mar 31 22:09:23 GMT 2025 , Edited by admin on Mon Mar 31 22:09:23 GMT 2025
PRIMARY
ACTIVE MOIETY
LULIZUMAB PEGOL
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966